W. Dauer and S. Przedborski, Parkinson's disease: Mechanisms and models, Neuron, vol.39, pp.889-909, 2003.

I. Martin, V. L. Dawson, and T. M. Dawson, Recent advances in the genetics of Parkinson's disease, Annu Rev Genomics Hum Genet, vol.12, pp.301-325, 2011.

A. S. Najim-al-din, A. Wriekat, A. Mubaidin, M. Dasouki, and M. Hiari, Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome, Acta Neurol Scand, vol.89, pp.347-352, 1994.

A. Ramirez, Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat Genet, vol.38, pp.1184-1191, 2006.

D. Fonzo and A. , Italian Parkinson Genetics Network (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, vol.68, pp.1557-1562

J. S. Park, Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism, Hum Mutat, vol.32, pp.956-964, 2011.

H. Eiberg, Novel mutation in ATP13A2 widens the spectrum of Kufor-Rakeb syndrome (PARK9), Clin Genet, 2011.

K. Schmidt, D. M. Wolfe, B. Stiller, and D. A. Pearce, Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2, Biochem Biophys Res Commun, vol.383, issue.2, pp.198-202, 2009.

A. D. Gitler, Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity, Nat Genet, vol.41, pp.308-315, 2009.

J. Ugolino, S. Fang, C. Kubisch, and M. J. Monteiro, Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ERstress induced cell death, Hum Mol Genet, vol.20, pp.3565-3577, 2011.

B. Dehay, Pathogenic lysosomal depletion in Parkinson's disease, J Neurosci, vol.30, pp.12535-12544, 2010.

M. Vila, J. Bové, B. Dehay, N. Rodríguez-muela, and P. Boya, Lysosomal membrane permeabilization in Parkinson disease, Autophagy, vol.7, pp.98-100, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02439189

C. W. Olanow and K. Mcnaught, Parkinson's disease, proteins, and prions: Milestones, Mov Disord, vol.26, pp.1056-1071, 2011.

A. H. Schapira and P. Jenner, Etiology and pathogenesis of Parkinson's disease, Mov Disord, vol.26, pp.1049-1055, 2011.

D. C. Rubinsztein, In search of an "autophagomometer, Autophagy, vol.5, pp.585-589, 2009.

P. Boya and G. Kroemer, Lysosomal membrane permeabilization in cell death, Oncogene, vol.27, pp.6434-6451, 2008.

N. Kokkonen, Defective acidification of intracellular organelles results in aberrant secretion of cathepsin D in cancer cells, J Biol Chem, vol.279, pp.39982-39988, 2004.

D. Sulzer, Neuronal pigmented autophagic vacuoles: Lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease, J Neurochem, vol.106, pp.24-36, 2008.

J. P. Luzio, P. R. Pryor, and N. A. Bright, Lysosomes: Fusion and function, Nat Rev Mol Cell Biol, vol.8, pp.622-632, 2007.

J. P. Luzio, Membrane dynamics and the biogenesis of lysosomes, Mol Membr Biol, vol.20, issue.2, pp.141-154, 2003.

R. Ruivo, A. C. Sagné, C. Gasnier, and B. , Molecular and cellular basis of lysosomal transmembrane protein dysfunction, Biochim Biophys Acta, vol.1793, pp.636-649, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00415318

V. Khurana, Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo, PLoS Genet, vol.6, p.1001026, 2010.

Y. Chu, H. Dodiya, P. Aebischer, C. W. Olanow, and J. H. Kordower, Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions, Neurobiol Dis, vol.35, pp.385-398, 2009.

A. Rosenbaum, H. Gershoni-baruch, and R. , Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews, N Engl J Med, vol.351, pp.1972-1977, 2004.

O. Goker-alpan, B. K. Stubblefield, B. I. Giasson, and E. Sidransky, Glucocerebrosidase is present in ?-synuclein inclusions in Lewy body disorders, Acta Neuropathol, vol.120, pp.641-649, 2010.

J. R. Mazzulli, Gaucher disease glucocerebrosidase and ?-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, vol.146, pp.37-52, 2011.

J. L. Webb, B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein, Alpha-Synuclein is degraded by both autophagy and the proteasome, J Biol Chem, vol.278, pp.25009-25013, 2003.

S. K. Mak, A. L. Mccormack, A. B. Manning-bog, A. M. Cuervo, D. Monte et al., Lysosomal degradation of alpha-synuclein in vivo, J Biol Chem, vol.285, pp.13621-13629, 2010.

A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer, Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy, Science, vol.305, pp.1292-1295, 2004.

M. Martinez-vicente, Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy, J Clin Invest, vol.118, pp.777-788, 2008.

T. L. Yap, Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases, J Biol Chem, vol.286, pp.28080-28088, 2011.

D. Sevlever, P. Jiang, and S. H. Yen, Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species, Biochemistry, vol.47, pp.9678-9687, 2008.

A. Jang, Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions, J Neurochem, vol.113, pp.1263-1274, 2010.

L. Alvarez-erviti, Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission, Neurobiol Dis, vol.42, pp.360-367, 2011.

J. A. Steiner, E. Angot, and P. Brundin, A deadly spread: Cellular mechanisms of ?-synuclein transfer, Cell Death Differ, vol.18, pp.1425-1433, 2011.

J. Bové, M. Martínez-vicente, and M. Vila, Fighting neurodegeneration with rapamycin: Mechanistic insights, Nat Rev Neurosci, vol.12, pp.437-452, 2011.